• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Global Patient Involvement in Sarcoma Care-A Collaborative Initiative of the Connective Tissue Oncology Society (CTOS) & Sarcoma Patients EuroNet (SPAEN).全球患者参与肉瘤护理——结缔组织肿瘤学会(CTOS)与欧洲肉瘤患者网络(SPAEN)的合作倡议。
Cancers (Basel). 2022 Feb 9;14(4):854. doi: 10.3390/cancers14040854.
2
An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).关于散发性硬纤维瘤样纤维瘤病(desmoid-type fibromatosis)治疗的最新进展:肉瘤患者欧洲网络(Sarcoma PAtients EuroNet,SPAEN)和欧洲癌症研究与治疗组织(European Organization for Research and Treatment of Cancer,EORTC)/软组织和骨肿瘤研究组(Soft Tissue and Bone Sarcoma Group,STBSG)之间的欧洲共识倡议。
Ann Oncol. 2017 Oct 1;28(10):2399-2408. doi: 10.1093/annonc/mdx323.
3
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.上皮样血管内皮细胞瘤,一种超罕见的癌症:来自专家社区的共识文件。
ESMO Open. 2021 Jun;6(3):100170. doi: 10.1016/j.esmoop.2021.100170. Epub 2021 Jun 2.
4
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).平滑肌肉瘤患者未满足的医疗需求及未来展望——来自国家平滑肌肉瘤基金会(NLMSF)和欧洲肉瘤患者网络(SPAEN)的立场文件
Cancers (Basel). 2021 Feb 20;13(4):886. doi: 10.3390/cancers13040886.
5
Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnership.与患者和照护者共同制定肉瘤国际研究议程:肉瘤患者欧洲网络(SPAEN)优先事项设定伙伴关系的初步结果。
ESMO Open. 2022 Jun;7(3):100509. doi: 10.1016/j.esmoop.2022.100509. Epub 2022 Jun 14.
6
Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative.散发性韧带样型纤维瘤病的治疗:基于患者和专业人员专业知识的欧洲共识方法——肉瘤患者欧洲网络和欧洲癌症研究与治疗组织/软组织和骨肿瘤组的倡议。
Eur J Cancer. 2015 Jan;51(2):127-36. doi: 10.1016/j.ejca.2014.11.005. Epub 2014 Nov 27.
7
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.回顾性观察性研究在超罕见肉瘤中的应用:结缔组织肿瘤学会(CTOS)专家社区关于系统治疗疗效评估最低要求的共识文件。
Cancer Treat Rev. 2022 Nov;110:102455. doi: 10.1016/j.ctrv.2022.102455. Epub 2022 Aug 18.
8
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.罕见肉瘤:结缔组织肿瘤学会专家组关于发病率阈值和实体列表的共识文件。
Cancer. 2021 Aug 15;127(16):2934-2942. doi: 10.1002/cncr.33618. Epub 2021 Apr 28.
9
What Is a Sarcoma 'Specialist Center'? Multidisciplinary Research Finds an Answer.什么是肉瘤“专科中心”?多学科研究给出答案。
Cancers (Basel). 2024 May 13;16(10):1857. doi: 10.3390/cancers16101857.
10
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.《韧带样纤维瘤的治疗管理:成人和儿童患者基于全球共识的联合指南方法》
Eur J Cancer. 2020 Mar;127:96-107. doi: 10.1016/j.ejca.2019.11.013. Epub 2020 Jan 28.

引用本文的文献

1
Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally.以患者为中心的结局的全球视角:在全球推进以患者为中心的癌症临床试验。
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):35-41. doi: 10.1093/jncimonographs/lgae043.
2
Enhancing rare cancer care in developing countries through patient advocacy: insights from the Desmoid Tumor Brazilian Association.通过患者宣传增强发展中国家的罕见癌症护理:来自巴西硬纤维瘤肿瘤协会的见解。
Ther Adv Med Oncol. 2025 Jan 9;17:17588359241309827. doi: 10.1177/17588359241309827. eCollection 2025.
3
From Data Integration to Precision Medicine: A Value-Based Healthcare Approach for Sarcoma Care.从数据整合到精准医学:一种基于价值的肉瘤护理医疗方法。
J Clin Med. 2024 Oct 30;13(21):6500. doi: 10.3390/jcm13216500.
4
Setting the international research agenda for sarcomas with patients and carers: results of phase II of the Sarcoma Patient Advocacy Global Network (SPAGN) priority setting partnership.为肉瘤患者和照护者设定国际研究议程:肉瘤患者倡导全球网络(SPAGN)优先事项设定伙伴关系第二阶段的结果。
BMC Cancer. 2024 Aug 6;24(1):962. doi: 10.1186/s12885-024-12732-6.
5
Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnership.与患者和照护者共同制定肉瘤国际研究议程:肉瘤患者欧洲网络(SPAEN)优先事项设定伙伴关系的初步结果。
ESMO Open. 2022 Jun;7(3):100509. doi: 10.1016/j.esmoop.2022.100509. Epub 2022 Jun 14.

本文引用的文献

1
Meaningful engagement of the patient in rare cancer research: sarcoma as an exemplar.有意义地让患者参与罕见癌症研究:以肉瘤为例。
Curr Probl Cancer. 2021 Aug;45(4):100772. doi: 10.1016/j.currproblcancer.2021.100772. Epub 2021 Jul 1.
2
The challenge of sarcomas: the patient advocacy group perspective.肉瘤的挑战:患者倡导组织的观点。
Clin Sarcoma Res. 2019 Jul 17;9:11. doi: 10.1186/s13569-019-0121-6. eCollection 2019.
3
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.参考中心的手术可提高肉瘤患者的生存率:一项全国性研究。
Ann Oncol. 2019 Jul 1;30(7):1143-1153. doi: 10.1093/annonc/mdz124.
4
Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database.腹膜后肉瘤外科治疗的生存获益:来自 NetSarc 数据库的法国肉瘤研究组的全国性研究。
Ann Surg Oncol. 2019 Jul;26(7):2286-2293. doi: 10.1245/s10434-019-07421-9. Epub 2019 May 7.
5
Age-related sarcoma patient experience: results from a national survey in England.与年龄相关的肉瘤患者体验:来自英格兰全国性调查的结果。
BMC Cancer. 2018 Oct 17;18(1):991. doi: 10.1186/s12885-018-4866-8.
6
The evolving role of patient advocates in rare cancers: opportunities and challenges.患者倡导者在罕见癌症中不断演变的角色:机遇与挑战。
Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):1-3. doi: 10.1080/14737167.2019.1526083. Epub 2018 Sep 27.
7
Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.促进癌症研究中的科学家-倡导者合作:为什么以及如何。
Cancer Res. 2018 Oct 15;78(20):5723-5728. doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17.
8
Transforming research: engaging patient advocates at all stages of cancer research.变革性研究:在癌症研究的各个阶段让患者权益倡导者参与进来。
Ann Transl Med. 2018 May;6(9):167. doi: 10.21037/atm.2018.04.46.
9
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.欧洲罕见肿瘤的负担和集中治疗:RARECAREnet 一项基于人群的研究结果。
Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4.
10
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group.成人复发性腹膜后肉瘤(RPS)的管理:跨大西洋RPS工作组的共识方法。
Ann Surg Oncol. 2016 Oct;23(11):3531-3540. doi: 10.1245/s10434-016-5336-7. Epub 2016 Aug 1.

全球患者参与肉瘤护理——结缔组织肿瘤学会(CTOS)与欧洲肉瘤患者网络(SPAEN)的合作倡议。

Global Patient Involvement in Sarcoma Care-A Collaborative Initiative of the Connective Tissue Oncology Society (CTOS) & Sarcoma Patients EuroNet (SPAEN).

作者信息

Kasper Bernd, Schuster Kathrin, Wilson Roger, Bickley Sorrel, Blay Jean-Yves, Reinke Denise, Wartenberg Markus, Haas Rick

机构信息

Sarcoma Unit, Mannheim Cancer Center (MCC), Mannheim University Medical Center, University of Heidelberg, 68167 Mannheim, Germany.

Sarcoma Patients EuroNet, SPAEN, 61200 Wölfersheim, Germany.

出版信息

Cancers (Basel). 2022 Feb 9;14(4):854. doi: 10.3390/cancers14040854.

DOI:10.3390/cancers14040854
PMID:35205602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8870105/
Abstract

Sarcomas are a grouping of rare cancers with a wide variety of histological types that are difficult to diagnose and treat. This leads to many varying challenges not only for sarcoma patients, but also for doctors, researchers, and caregivers. Patient advocacy groups have an important role to play in rare cancers such as sarcomas, especially in collaboration with experts and their medical societies. To this end, patients and patient advocates from Sarcoma Patients EuroNet (SPAEN), a global network of national Sarcoma Patient Advocacy Groups, and medical experts from the scientifically driven Connective Tissue Oncology Society (CTOS) came together on 9 November 2021 at an official ancillary event to the CTOS 2021 Annual Meeting. At the event, representatives of CTOS and SPAEN jointly discussed gaps and challenges in global sarcoma care and management. This resulting position paper highlights the main findings and possible future steps.

摘要

肉瘤是一组罕见癌症,具有多种组织学类型,难以诊断和治疗。这不仅给肉瘤患者带来诸多不同挑战,也给医生、研究人员和护理人员带来挑战。患者倡导组织在肉瘤等罕见癌症中发挥着重要作用,尤其是与专家及其医学协会合作时。为此,来自全球国家肉瘤患者倡导组织网络“欧洲肉瘤患者网络”(SPAEN)的患者和患者倡导者,以及来自以科学为导向的结缔组织肿瘤学会(CTOS)的医学专家,于2021年11月9日在CTOS 2021年会的一次官方附属活动上齐聚一堂。在此次活动中,CTOS和SPAEN的代表共同讨论了全球肉瘤护理和管理方面的差距与挑战。这份形成的立场文件突出了主要发现以及未来可能采取的步骤。